» Articles » PMID: 20947482

Updating Controversies on the Multidisciplinary Management of Gastric Cancer

Overview
Specialty Oncology
Date 2010 Oct 16
PMID 20947482
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The rates of relapse and death remain high in gastric cancer patients, especially in advanced stages. Local relapses in the tumour bed and regional lymph nodes, peritoneal spread as abdominal carcinomatosis, and distant metastasis are common mechanisms of failure after a R0 resection. To overcome this, a multidisciplinary approach has been prompted. In recent years, multidisciplinary treatment has been strengthened by some randomised controlled trials and it is now considered the standard by most groups, although the improvement in long-term survival rates achieved is still limited. This new therapeutic approach in gastric cancer is rapidly evolving and has led to a series of controversies on the best strategy to follow. Some of these controversies are discussed in this paper.

Citing Articles

Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.

Han F, Zhou S, Li H, He Y, Zhan W World J Gastroenterol. 2016; 22(14):3813-20.

PMID: 27076766 PMC: 4814744. DOI: 10.3748/wjg.v22.i14.3813.

References
1.
Siewert J, Feith M, Stein H . Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005; 90(3):139-46. DOI: 10.1002/jso.20218. View

2.
de Gara C, Hanson J, Hamilton S . A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg. 2003; 186(1):23-7. DOI: 10.1016/s0002-9610(03)00116-8. View

3.
Xu D, Zhan Y, Sun X, Cao S, Geng Q . Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol. 2004; 10(18):2727-30. PMC: 4572202. DOI: 10.3748/wjg.v10.i18.2727. View

4.
Yang K, Chen X, Hu J, Zhang B, Chen Z, Chen J . Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis. World J Gastroenterol. 2009; 15(42):5352-9. PMC: 2776865. DOI: 10.3748/wjg.15.5352. View

5.
Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V . Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999; 79(9-10):1522-30. PMC: 2362742. DOI: 10.1038/sj.bjc.6690243. View